Pharmaceutical Commerce
Pharmaceutical Commerce is a publication aimed at biopharma executives who make key business decisions. It highlights the processes and technologies that play a role in bringing approved drugs to market. Our editorial content is designed to enhance teamwork among management professionals, ultimately aiming to lower the costs associated with commercial operations.
Outlet metrics
Global
#1895227
United States
#766329
Health/Biotechnology and Pharmaceuticals
#734
Articles
-
6 days ago |
pharmaceuticalcommerce.com | Nicholas Saraceno
In a video interview with Pharma Commerce, Jody Hatcher, CEO of Morris & Dickson and chair of HDA’s board of directors, outlines his vision for the future of the organization and the key priorities he hopes to drive during his tenure. He expresses a strong sense of privilege and responsibility in succeeding Kirk Kaminsky and looks forward to collaborating closely with Debbie Weitzman of Cardinal Health to strengthen connections across the pharmaceutical supply chain.
-
6 days ago |
pharmaceuticalcommerce.com | Don Tracy
Bringing Biotech Innovation Across BordersA feature published by Pharmaceutical Executive authored by Ed Ahn, CEO of MEDIPOST, Inc, outlines four tips for midsized companies when entering new global markets.
-
1 week ago |
pharmaceuticalcommerce.com | Nicholas Saraceno
PC: How do you manage to keep the program itinerary organized year after year? Robinson: While we have a broader global LogiPharma portfolio, my team now focuses solely on this event. These days, it’s a year-round project—365 days. Once this year’s event wraps, I’ll be thanking our speakers and delegates and immediately starting research conversations for 2026. Before we even draft the agenda, we aim to conduct 150 to 200 hours of research calls.
-
1 week ago |
pharmaceuticalcommerce.com | Nicholas Saraceno
In a video interview with Pharma Commerce, Jody Hatcher, CEO of Morris & Dickson and chair of HDA’s board of directors, outlines his vision for the future of the organization and the key priorities he hopes to drive during his tenure. He expresses a strong sense of privilege and responsibility in succeeding Kirk Kaminsky and looks forward to collaborating closely with Debbie Weitzman of Cardinal Health to strengthen connections across the pharmaceutical supply chain.
-
1 week ago |
pharmaceuticalcommerce.com | Don Tracy
The FDA has granted interchangeability designation to Celltrion’s Yuflyma (adalimumab-aaty), a high-concentration (100 mg/mL), citrate-free biosimilar of Humira (adalimumab), across multiple inflammatory indications.
Pharmaceutical Commerce journalists
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →